Alfuzosin
Alfuzosin is a pharmaceutical drug with 25 clinical trials. Historical success rate of 87.0%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.0%
20 of 23 finished
13.0%
3 ended early
0
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Symptom-specific Goal Achievement
The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Clinical Trials (25)
Evaluation of Symptom-specific Goal Achievement
The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia
Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology
Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers
The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones
Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
ALF-ONE : ALFuzosin ONcE Daily
Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
Alfuzosin for Treating Acute Urinary Retention
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
Once Daily Given Alfuzosin in the Treatment of BPH
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25